MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Neuroprotective Effects of ATP6V0C Overexpression in PFF Model Mice

Y. Wang, Y. Xia, L. Kou, T. Wang (wuhan, China)

Meeting: 2025 International Congress

Keywords: Alpha-synuclein, Lysosomal disorders, Parkinson’s

Category: Parkinson's Disease: Pathophysiology / molecular mechanisms of disease

Objective: Elucidating the role of lysosomal dysfunction due to altered stability and expression levels of V-type proton subunit ATP6V0C in the degradation and propagation of pathological protein α-synuclein.

Background: Parkinson’s disease (PD) primarily involves a disruption in protein homeostasis, resulting in the abnormal aggregation of α-synuclein (α-syn). Lysosomes play a crucial role in clearing aggregated proteins and damaged organelles. Studies indicate that lysosomal function is impaired in the brains of PD patients, but the precise mechanism of this impairment is not fully understood. The normal physiological function of lysosomal is dependent on an appropriate range of pH, which is highly dependent on the V-ATPases acting as proton pumps to pump protons into the lysosomal lumen. Therefore, alterations in the stability and expression level of ATP6V0C, as one of the subunits of the V0 portion of the v-ATPase, may impair the activity of the v-ATPase, which is involved in the degradation and propagation of α-syn by regulating lysosomal PH. Thus, ATP6V0C overexpression may play a neuroprotective role via acidification of lysosomes and enhanced degradation of α-syn.

Method: This study used mice with stereotaxic injection of α-syn PFF into the striatum as animal models of PD. An adeno-associated virus-mediated strategy was used to overexpress ATP6V0C in the striatum of PFF model mice. Mouse motor function was evaluated through Rotarod test, Pole test, and Hang tests. The levels of TH and phosphorylated α-syn in the substantia nigra and striatum of mice were detected using immunofluorescence and immunohistochemical staining.

Results: We found that ATP6V0C expression is reduced in α-syn PFF model mice (Figure 1). Overexpressing ATP6V0C mitigates motor deficits, prevents dopaminergic neuron loss in the substantia nigra (Figure 1), and reduces the aggregation of phosphorylated α-syn in the striatum and substantia nigra (Figure 2). In brief, ATP6V0C overexpression exerts neuroprotective effects in PFF model mice.

Conclusion: Pathogenic protein accumulation is a key feature of PD, and compromised V-type ATPase dysfunction might participate in PD pathogenesis. ATP6V0C overexpression exerts neuroprotective effects in PFF model mice, which may provide opportunities to develop novel therapeutic strategies for PD.

Neuroprotective effects of overexpressing ATP6V0C

Neuroprotective effects of overexpressing ATP6V0C

Neuroprotective effects of overexpressing ATP6V0C

Neuroprotective effects of overexpressing ATP6V0C

To cite this abstract in AMA style:

Y. Wang, Y. Xia, L. Kou, T. Wang. Neuroprotective Effects of ATP6V0C Overexpression in PFF Model Mice [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/neuroprotective-effects-of-atp6v0c-overexpression-in-pff-model-mice/. Accessed October 5, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/neuroprotective-effects-of-atp6v0c-overexpression-in-pff-model-mice/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley